<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00524641</url>
  </required_header>
  <id_info>
    <org_study_id>NIS-RVN-SYM-2007/1</org_study_id>
    <secondary_id>NIS-R84-AST-2007/3</secondary_id>
    <nct_id>NCT00524641</nct_id>
  </id_info>
  <brief_title>Asthma Control-A &quot;Patient Follow up Programme&quot; Maintenance and Reliever Therapy in a Single Inhaler</brief_title>
  <official_title>A Patient Follow-up Program to Assess Asthma Control in Patients Using Symbicort® as Maintenance and Relief Therapy in a Single Inhaler (Symbicort® SMART: Budesonide/Formoterol 160/4.5 Mcg, 1 or 2 Inhalations x 2 Times Plus Additional Inhalations as Needed)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>AstraZeneca</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>AstraZeneca</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To investigate the change in patient's asthma symptom control using ACQ scores after 4 to 6
      weeks of Symbicort Turbuhaler (budesonide/ formoterol) in SMART approach.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">April 2008</completion_date>
  <primary_completion_date type="Actual">March 2008</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <enrollment type="Actual">1254</enrollment>
  <condition>Asthma</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Hospital out-patient departments and private clinics in all areas of Vietnam
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Asthma patients from both sexes, age 18 or older

          -  Have already been on Symbicort SMART treatment

          -  Willing to give written informed consents to participate in the program.

        Exclusion Criteria:

          -  Patients who are not willing to give written informed consent

          -  Patients in emergency care for asthma at ICUs or COPD patients are excluded from the
             program.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dinh Ngoc SY, MD</last_name>
    <role>Study Chair</role>
    <affiliation>TB and Lung Disease Hospital, Hanoi</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Tran Van Ngoc, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Cho Ray Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Nguyen Hong Duc</last_name>
    <role>Study Chair</role>
    <affiliation>Pharm Ngoc Thach Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Do Van Dung, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Ho Chi Minh City Univ of Medicine and Pharmacist</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Hanoi</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Research Site</name>
      <address>
        <city>Ho Chi Minh City</city>
        <country>Vietnam</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Vietnam</country>
  </location_countries>
  <link>
    <url>http://www.astrazeneca.com/node/emailtriage.aspx</url>
  </link>
  <verification_date>July 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 30, 2007</study_first_submitted>
  <study_first_submitted_qc>August 31, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 3, 2007</study_first_posted>
  <last_update_submitted>July 8, 2009</last_update_submitted>
  <last_update_submitted_qc>July 8, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2009</last_update_posted>
  <keyword>Asthma</keyword>
  <keyword>Symbicort</keyword>
  <keyword>NIS</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Asthma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Budesonide, Formoterol Fumarate Drug Combination</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

